Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| VKTX | VIKING THERAPEUTICS INC | $3.34B | 116,105,643 | 63.02% | 8.85% | Net Selling | |||
| EQT | EQT CORP | $32.49B | 625,478,000 | 88.20% | 11.80% | Net Selling | Net Selling | ||
| BNTX | BIONTECH SE | $21.73B | 239,970,804 | 19.75% | 17.34% | Net Selling | Net Selling | ||
| SLDB | SOLID BIOSCIENCES INC | $702.93M | 98,449,606 | 60.19% | 39.81% | Net Selling | |||
| PCVX | VAXCYTE INC | $6.85B | 144,397,682 | 89.00% | 11.00% | Net Selling | Net Selling | ||
| CGEM | CULLINAN THERAPEUTICS INC | $841.98M | 61,458,046 | 57.24% | 42.76% | Net Buying | Net Selling | ||
| HIVE | HIVE DIGITAL TECHNOLOGIES LTD | $997.52M | 267,430,821 | 30.52% | 0.78% | Net Selling | Net Selling | ||
| CATX | PERSPECTIVE THERAPEUTICS INC | $336.44M | 114,046,197 | 41.47% | 58.53% | Net Buying | |||
| ODTX | ODYSSEY THERAPEUTICS INC | N/A | 44,994,769 | 0.00% | 27.59% | Net Buying | Net Buying | ||
| KLRA | KAILERA THERAPEUTICS INC | $2.45B | 129,565,608 | 0.00% | 85.31% | Net Buying | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.